CIK 0001253689 · Non-accelerated filer<br>Smaller reporting company
CRESCENT BIOPHARMA, INC.
Sign in to watch- Ticker
- CBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- Phone
- 617-430-5595
- Business address
- 300 FIFTH AVENUE, WALTHAM, MA, 02451
- Former names
- GLYCOMIMETICS INC
- 4 Grant or award President, CEO acquired 96,250 shares (grant or award)
- 4 Open-market sale President, CEO sold 84,176 shares at $3.91 ($329,128)
- 4 Option exercise SVP Finance, CFO acquired 5,260 shares (option exercise)
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market buy 10% owner bought 1,266,737 shares at $2.60 ($3,293,516)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Open-market buy 10% owner bought 932,612 shares at $2.75 ($2,564,683)
- 424B5 Offering Prospectus
- 8-K Event Material agreement
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 18 of 34 · 678 filings